Panacea Life Sciences Holdings, Inc.
Cash Flow Statement
| Line Item | FY2015 | FY2014 |
|---|---|---|
| Operating Activities | ||
| Net Income | $-358.0K | $-296.6K |
| Depreciation & Amortization | $1.6K | $1.8K |
| Depreciation | — | — |
| Amortization | — | — |
| Stock-Based Compensation | $5.0K | $55.0K |
| Net Cash from Operating Activities | $-640.0K | $-399.7K |
| Investing Activities | ||
| Capital Expenditures | $0 | $6.0K |
| Business Acquisitions | — | — |
| Net Cash from Investing Activities | $0 | $-9.6K |
| Financing Activities | ||
| Dividends Paid | — | — |
| Stock Repurchases | — | — |
| Net Cash from Financing Activities | $598.3K | $415.5K |
| Net Change in Cash | $-41.7K | $6.2K |
| Free Cash Flow | $-640.0K | $-405.7K |